Related references
Note: Only part of the references are listed.A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
Dora Liu et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2013)
Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?
A. Kirstin Bacani et al.
ARTHRITIS AND RHEUMATISM (2012)
Early Vascular Alterations in SLE and RA Patients-A Step towards Understanding the Associated Cardiovascular Risk
Maria Jose Santos et al.
PLOS ONE (2012)
Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study
Sreeram V. Ramagopalan et al.
BMC MEDICINE (2011)
The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases
Paolo Puddu et al.
CANADIAN JOURNAL OF CARDIOLOGY (2011)
Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism
M. Schmidt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis
Terence Rooney et al.
RHEUMATOLOGY (2011)
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications
Armen Yuri Gasparyan et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors
B. van Zaane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Thrombin-activatable fibrinolysis inhibitor and its relation with inflammation in rheumatoid arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Cardiovascular morbidity and mortality in rheumatoid arthritis
Sherine E. Gabriel
AMERICAN JOURNAL OF MEDICINE (2008)
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade
Francesca Ingegnoli et al.
JOURNAL OF AUTOIMMUNITY (2008)
Mechanisms of disease:: Platelet activation and atherothrombosis
Giovanni Davi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
Vokko P. van Halm et al.
ARTHRITIS RESEARCH & THERAPY (2006)
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
P Cirillo et al.
CARDIOVASCULAR RESEARCH (2005)
Coagulation inhibitors in inflammation
CT Esmon
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Bidirectional relation between inflammation and coagulation
M Levi et al.
CIRCULATION (2004)
Activated factor XII in rheumatoid arthritis
M McLaren et al.
RHEUMATOLOGY INTERNATIONAL (2002)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis
A McEntegart et al.
RHEUMATOLOGY (2001)
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
JS Yudkin et al.
ATHEROSCLEROSIS (2000)
Share Paper
